954 — Changmao Biochemical Engineering Co Share Price
- HK$150.96m
- HK$642.23m
- CNY584.79m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.24 | ||
Price to Tang. Book | 0.24 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.24 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -8.84% | ||
Return on Equity | -11.05% | ||
Operating Margin | -9.76% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 444.11 | 547.98 | 730.03 | 637.08 | 584.79 | n/a | n/a | 3.41% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -49.09 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Changmao Biochemical Engineering Co Ltd is a China-based company principally engaged in the production and sales of organic acids products. Along with its subsidiaries, The Company produces organic acids products for sales to food additive, chemical and pharmaceutical industries. The core products of the Company are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid and aspartame. These products are mainly used as food additives or medical intermediaries. The Company operates its business in domestic market and overseas markets.
Directors
- Xin Sheng Rui CHM (58)
- Chun Pan CEO (45)
- Yi Dong Wan DGM (41)
- A. Xing Lu OTH (45)
- Qin Ying Zhang OTH (45)
- Pui Ling Wan SEC (43)
- Yi Xin Leng NED (53)
- Jian Ping Wang NED (53)
- Xiao Ping Yu NED (59)
- Xian Biao Zeng NED (72)
- Fung Lan Au NID (40)
- Ping Kai Ouyang NID (69)
- Xin Wei NID (47)
- Sheng Li Yang NID (74)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 3rd, 1992
- Public Since
- June 28th, 2002
- No. of Employees
- 582
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 529,700,000

- Address
- No. 1228, CHANGZHOU, 213034
- Web
- https://www.cmbec.cn
- Phone
- +86 51985776801
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 954
Changmao Biochemical Engineering Co Ltd Annual Shareholders Meeting
Similar to 954
Century Energy International Holdings
Stock Exchange of Hong Kong Limited
China Gas Industry Investment Holdings Co
Stock Exchange of Hong Kong Limited
Zhejiang ChangAn Renheng Technology Co
Stock Exchange of Hong Kong Limited
China BlueChemical
Stock Exchange of Hong Kong Limited
China Glass Holdings
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:52 UTC, shares in Changmao Biochemical Engineering Co are trading at HK$0.29. This share price information is delayed by 15 minutes.
Shares in Changmao Biochemical Engineering Co last closed at HK$0.29 and the price had moved by -30.49% over the past 365 days. In terms of relative price strength the Changmao Biochemical Engineering Co share price has underperformed the FTSE Developed Asia Pacific Index by -29.69% over the past year.
There is no consensus recommendation for this security.
Find out moreChangmao Biochemical Engineering Co does not currently pay a dividend.
Changmao Biochemical Engineering Co does not currently pay a dividend.
Changmao Biochemical Engineering Co does not currently pay a dividend.
To buy shares in Changmao Biochemical Engineering Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.29, shares in Changmao Biochemical Engineering Co had a market capitalisation of HK$150.96m.
Here are the trading details for Changmao Biochemical Engineering Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 954
Based on an overall assessment of its quality, value and momentum Changmao Biochemical Engineering Co is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Changmao Biochemical Engineering Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -32.14%.
As of the last closing price of HK$0.29, shares in Changmao Biochemical Engineering Co were trading -30.52% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Changmao Biochemical Engineering Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.29.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Changmao Biochemical Engineering Co's management team is headed by:
- Xin Sheng Rui - CHM
- Chun Pan - CEO
- Yi Dong Wan - DGM
- A. Xing Lu - OTH
- Qin Ying Zhang - OTH
- Pui Ling Wan - SEC
- Yi Xin Leng - NED
- Jian Ping Wang - NED
- Xiao Ping Yu - NED
- Xian Biao Zeng - NED
- Fung Lan Au - NID
- Ping Kai Ouyang - NID
- Xin Wei - NID
- Sheng Li Yang - NID